Spots Global Cancer Trial Database for Study of the Immune Response in Colon Adenocarcinoma
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Study of the Immune Response in Colon Adenocarcinoma
Official Title: Etude de la réponse Immunitaire Dans l'adénocarcinome Colique
Study ID: NCT03015038
Conditions
Interventions
Study Description
Brief Summary: Duration of each part of the study per patient: * Screening: From 1 to 4 weeks * Sampling period (blood and tissue): 1 day * Follow-up by patient: 60 months * Total study duration by patient: 84 months * Total inclusion duration: 24 months * Total Follow-up duration: 60 months * Total study duration: 84 months
Detailed Description:
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Hôpital Saint Louis, Paris, , France
Contact Details
Name: Matthieu Allez, MD, PhD
Affiliation: Hopital Saint Louis
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
